STOCK TITAN

HeartCore Q3 revenue falls to $162K; loss hits $596K

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

HeartCore Enterprises, Inc. reported third-quarter 2026 revenue of $162,409, compared with $1,242,985 a year earlier, and a net loss of $596,434 versus net income of $351,175. Gross profit was $16,055, compared with $1,101,525; Adjusted EBITDA was a loss of $1.1 million, versus positive Adjusted EBITDA of $0.4 million. For the first nine months, revenue was $269,852 versus $1,666,519, and net loss was $3,792,658 versus $1,724,700.

As of September 30, 2026, cash and cash equivalents were $976,594. HeartCore completed the transfer of its 51% interest in HeartCore Luvina Vietnam Company Limited to Luvina Software Joint Stock Company for JPY 29,000,000 (approximately $184,000). Together with its June 2026 divestiture of Sigmaways, Inc., the transaction concluded the company’s exit from software development services. HeartCore reported 16 Go IPO clients, including six preparing for potential IPOs and U.S. exchange listings, and a non-exclusive Japanese sales-agency agreement with ONE AI to support its commercial expansion in the robotics market, with commission-based revenue.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 2 points

How the balance works

Positive

  • None.

Negative

  • Moderate pointThird-quarter revenue was $162,409, compared with $1,242,985 a year earlier.
  • Moderate pointNine-month net loss was $3,792,658, compared with $1,724,700 a year earlier.

Filing Explained

HeartCore reported 1,515,328 common shares issued and outstanding on September 30, 2026, versus 1,270,991 on December 31, 2025; an existing holder whose share count is unchanged has a lower percentage ownership in the larger share base, absent offsets.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Third-quarter revenue $162,409 Three months ended September 30, 2026; compared with $1,242,985 in 2025
Third-quarter net loss $596,434 Three months ended September 30, 2026; compared with net income of $351,175 in 2025
Third-quarter Adjusted EBITDA $(1.1) million Three months ended September 30, 2026; compared with $0.4 million in 2025
Nine-month revenue $269,852 Nine months ended September 30, 2026; compared with $1,666,519 in 2025
Nine-month net loss $3,792,658 Nine months ended September 30, 2026; compared with $1,724,700 in 2025
Cash and cash equivalents $976,594 As of September 30, 2026; compared with $1,530,967 as of December 31, 2025
HeartCore Luvina equity interest transferred 51% Transferred to Luvina Software Joint Stock Company for JPY 29,000,000 (approximately $184,000)
Go IPO clients 16 clients, including 6 in preparation for potential IPOs and U.S. exchange listings As of September 30, 2026
Adjusted EBITDA financial
"Adjusted EBITDA, which is a non-GAAP financial measure"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
non-GAAP financial measure financial
"Adjusted EBITDA, which is a non-GAAP financial measure"
A non-GAAP financial measure is a way companies present their financial results that excludes certain expenses or income to show how they believe their core business is performing. It matters because it can give a clearer picture of how the company is really doing, but it can also be used to make results look better than they actually are.
discontinued operations financial
"Income (loss) from discontinued operations, net of income tax"
Discontinued operations are parts of a company that it has decided to sell or shut down, and no longer plans to run in the future. This matters to investors because it helps them understand which parts of the business are ongoing and which are being phased out, providing a clearer picture of the company’s current performance and future prospects. Think of it like a store closing a department—it no longer contributes to sales or profits.
derivative liability financial
"Changes in fair value of derivative liability"
A derivative liability is an obligation a company owes because of a derivatives contract—such as an option, future, swap, or forward—that has moved against it and now has negative value. Think of it like a settled bet that turned into a bill: if market moves go the other way, the company may have to pay cash or deliver assets. Investors care because these liabilities can create sudden losses, add leverage or counterparty risk, and change a company’s true financial exposure beyond its everyday operations.
operating lease right-of-use assets financial
"Operating lease right-of-use assets obtained in exchange for operating lease liabilities"
An operating lease right-of-use (ROU) asset is an accounting entry that shows the value of a leased item you have the legal right to use—like a building, vehicle, or equipment—recorded on a company’s balance sheet along with the corresponding lease obligation. Investors care because it adds to reported assets and liabilities, changing measures like leverage and return on assets much like bringing a long-term rental onto the company’s financial snapshot, which can affect credit terms and valuation.
Third-quarter revenue $162,409 Compared with $1,242,985 in 2025
Third-quarter gross profit $16,055 Compared with $1,101,525 in 2025
Third-quarter net income (loss) Net loss of $596,434 Compared with net income of $351,175 in 2025
Third-quarter Adjusted EBITDA $(1.1) million Compared with $0.4 million in 2025
Nine-month revenue $269,852 Compared with $1,666,519 in 2025
Nine-month gross profit (loss) Gross loss of $259,710 Compared with gross profit of $1,334,557 in 2025
Nine-month net loss $3,792,658 Compared with $1,724,700 in 2025
Nine-month Adjusted EBITDA $(3.2) million Compared with $(0.8) million in 2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What was HTCR’s third-quarter 2026 revenue?

HeartCore reported revenue of $162,409 for the three months ended September 30, 2026, compared with $1,242,985 in the same period of 2025. The company attributed the decrease primarily to fewer Go IPO consulting clients and fewer successful client IPOs.

What was HeartCore’s net loss for the first nine months of 2026?

HeartCore reported a net loss of $3,792,658 for the nine months ended September 30, 2026, compared with a net loss of $1,724,700 in the same period of 2025. The company cited a shift from gross profit to gross loss, higher operating expenses and a loss from discontinued operations.

What were the terms of HeartCore’s HeartCore Luvina transfer?

HeartCore completed the transfer of its 51% equity interest in HeartCore Luvina Vietnam Company Limited to Luvina Software Joint Stock Company for JPY 29,000,000 (approximately $184,000). The company said the transaction, together with its June 2026 divestiture of Sigmaways, Inc., concluded its exit from software development services.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001892322 0001892322 2026-11-16 2026-11-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) November 16, 2026

 

HEARTCORE ENTERPRISES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41272   87-0913420
(State or other jurisdiction
of incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

 

14F, Shibuya Sakura Stage Central Building,

1-2 Sakuragaoka-cho,

Shibuya-ku, Tokyo, Japan

  150-0031
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code +81-3-6899-7114

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   HTCR   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On November 16, 2026, HeartCore Enterprises, Inc. issued a press release announcing financial results for the three and nine months ended September 30, 2026. A copy of this press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information contained in any website is not a part of this Current Report on Form 8-K.

 

The information included in this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
99.1   Press release of the registrant issued on November 16, 2026.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 16, 2026 HEARTCORE ENTERPRISES, INC.
     
  By: /s/ Sumitaka Yamamoto
    Sumitaka Yamamoto
    Chief Executive Officer

 

 

 

 

Exhibit 99.1

 

 

HeartCore Reports Third Quarter 2026 Financial Results

 

NEW YORK and TOKYO, November 16, 2026 (GLOBE NEWSWIRE) – HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, reported financial results for the third quarter and nine months ended September 30, 2026.

 

Recent Operational Highlights

 

●Entered into a non-exclusive business development and sales agency agreement in Japan with ONE AI, Co., Ltd. (“ONE AI”)
●As of September 30, 2026, HeartCore was engaged with 16 Go IPO clients, including 6 clients currently in various stages of preparation for potential initial public offerings and U.S. exchange listings.
●Announced and completed the transfer of the Company’s 51% equity interest in HeartCore Luvina Vietnam Company Limited (“HeartCore Luvina”) to Luvina Software Joint Stock Company for JPY 29,000,000 (approximately $184,000). Together with the June 2026 divestiture of Sigmaways, Inc., the transaction concludes the Company’s exit from software development services and concentrates its operations on Go IPO consulting, capital markets advisory, and financial services.

 

Management Commentary

 

HeartCore CEO Sumitaka Kanno commented: “With the transfer of our interest in HeartCore Luvina completed during the third quarter, we have concluded the portfolio optimization we began earlier this year. HeartCore now operates as a focused Go IPO consulting, capital markets advisory, and financial services company, which we believe allows us to direct management attention and capital toward the areas where we see the greatest long-term opportunity.

 

“The Nasdaq listing environment remains selective, and a number of our clients have extended their IPO timelines as they work to satisfy stricter exchange and regulatory requirements. We continue to prioritize clients that we believe demonstrate stronger fundamentals, organizational readiness, and a clear path to a U.S. listing, and we are cautiously optimistic that this disciplined approach will support a higher-quality pipeline over time.

 

“Beyond our core business, just last week, we announced a new business development and sales agency agreement with ONE AI. Under this agreement, we will support ONE AI’s commercial expansion into the Japanese robotics market. Importantly, the agreement introduces an additional commission-based revenue stream, further diversifying our revenue base as we continue to navigate the current U.S. listing environment.

 

“Looking ahead, we intend to maintain disciplined cost management as we work to convert our pipeline into new engagements and listing milestones. With a simpler structure in place, we expect our results going forward to more clearly reflect the performance of our core business.”

 

 
 

 

 

Third Quarter 2026 Financial Results

 

Revenues were $162,000 compared to $1.2 million in the same period last year. The decrease was primarily due to fewer Go IPO consulting clients and fewer successful client IPOs during the period.

 

Gross profit was $16,000 compared to $1.1 million in the same period last year. The decrease reflected lower Go IPO consulting revenues and higher consulting service costs, including increased outsourcing fees.

 

Operating expenses were $1.2 million compared to $899,000 in the same period last year. The increase was primarily due to higher general and administrative expenses, including salaries and benefits, restructuring-related consulting and professional fees, and rent, partially offset by lower selling expenses.

 

Net loss was $596,000 compared to net income of $351,000 in the same period last year. The change reflected lower gross profit, higher operating expenses, and a shift from income to a loss from discontinued operations, partially offset by net other income and an income tax benefit.

 

Adjusted EBITDA was $(1.1) million for the third quarter of 2026 compared to Adjusted EBITDA of $0.4 million in the same period last year.

 

Nine Months Ended September 30, 2026 Financial Results

 

Revenues were $270,000 compared to $1.7 million in the same period last year. The decrease was primarily due to fewer Go IPO consulting clients and fewer successful client IPOs during the period.

 

Gross loss was $260,000 compared to gross profit of $1.3 million in the same period last year. The change reflected lower Go IPO consulting revenues and higher service costs, including increased resources devoted to client service and higher outsourcing fees.

 

Operating expenses were $3.1 million compared to $2.8 million in the same period last year. The increase was primarily due to higher general and administrative expenses, including salaries and benefits, rent, and restructuring-related consulting and professional fees, partially offset by lower selling expenses and reductions in certain other administrative costs.

 

Net loss was $3.8 million compared to a net loss of $1.7 million in the same period last year. The increase reflected a shift from gross profit to gross loss, higher operating expenses, and a loss from discontinued operations compared to income in the prior-year period, partially offset by lower net other expenses and an income tax benefit.

 

Adjusted EBITDA was $(3.2) million for the nine months ended September 30, 2026, compared to Adjusted EBITDA of $(0.8) million in the same period last year.

 

As of September 30, 2026, the Company had cash and cash equivalents of $1.0 million compared to $1.5 million as of December 31, 2025.

 

 
 

 

 

About HeartCore Enterprises, Inc.

 

HeartCore Enterprises, Inc. is headquartered in Tokyo, Japan, and is a leading consulting services company providing U.S. market listing support and related advisory services primarily to Japanese corporate clients. For more information, please visit https://heartcore-enterprises.com/.

 

Non-GAAP Financial Measures

 

This document includes references to Adjusted EBITDA, which is a non-GAAP financial measure. For the purposes of this presentation, Adjusted EBITDA is calculated by adjusting net loss to exclude depreciation and amortization, changes in fair value of investments in marketable securities, changes in fair value of investment in warrants, changes in fair value of derivative liability, interest income, interest expenses, other income, and other expenses.

 

This measure is presented as supplemental information and is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the U.S. (“GAAP”).

 

Management believes that Adjusted EBITDA provides useful information to investors by highlighting the Company’s core operational performance, excluding non-cash and non-recurring items. However, non-GAAP financial measures have limitations and should not be considered in isolation or as a substitute for financial results prepared in accordance with GAAP.

 

   For the three months ended September 30, 
Item  2026   2025 
Net income (loss)  $(0.6) million   $0.4 million 
(+) Depreciation  $0.0 million   $0.0 million 
(+) Changes in fair value of investments in marketable securities  $(0.4) million   $(0.0) million 
(+) Changes in fair value of investment in warrants  $(0.0) million   $0.1 million 
(+) Changes in fair value of derivative liability  $0.0 million   $0.0 million 
(+) Interest income  $(0.0) million   $(0.0) million 
(+) Interest expenses  $0.0 million   $0.0 million 
(+) Other income  $(0.2) million   $(0.0) million 
(+) Other expenses  $0.0 million   $0.0 million 
Adjusted EBITDA  $(1.1) million   $0.4 million 

 

   For the nine months ended September 30, 
Item  2026   2025 
Net loss  $(3.8) million   $(1.7) million 
(+) Depreciation  $0.0 million   $0.0 million 
(+) Changes in fair value of investments in marketable securities  $0.4 million   $0.9 million 
(+) Changes in fair value of investment in warrants  $0.0 million   $0.1 million 
(+) Changes in fair value of derivative liability  $0.0 million   $0.0 million 
(+) Interest income  $(0.0) million   $(0.0) million 
(+) Interest expenses  $0.0 million   $0.0 million 
(+) Other income  $(0.2) million   $(0.0) million 
(+) Other expenses  $0.4 million   $0.0 million 
Adjusted EBITDA  $(3.2) million   $(0.8) million 

 

Note: Figures in the tables above are rounded to the nearest $0.1 million; therefore, totals may not sum due to rounding.

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

 

HeartCore Investor Relations Contact:

 

Gateway Group, Inc.

John Yi and Steven Shinmachi

HTCR@gateway-grp.com

(949) 574-3860

 

 
 

 

 

HEARTCORE ENTERPRISES, INC.

CONSOLIDATED BALANCE SHEETS

 

   September 30,   December 31, 
   2026   2025 
ASSETS          
Current assets:          
Cash and cash equivalents  $976,594   $1,530,967 
Accounts receivable   32,853    - 
Investments in marketable securities   1,380,553    3,690,187 
Prepaid expenses   82,351    127,242 
Deferred offering costs   250,000    250,000 
Other current assets   144,079    188,525 
Current assets of discontinued operations   -    1,337,673 
Proceeds receivable from sale of discontinued operations   483,082    1,291,298 
Total current assets   3,349,512    8,415,892 
           
Non-current assets:          
Property and equipment, net   255,872    275,465 
Operating lease right-of-use assets   352,524    16,986 
Long-term investment in warrants   130,916    280,924 
Long-term loan receivable   258,859    - 
Deferred tax assets   23,006    23,121 
Security deposits   276,199    278,342 
Other non-current assets   286    - 
Non-current assets of discontinued operations   -    33,752 
Long-term proceeds receivable from sale of discontinued operations   3,496,039    3,736,995 
Total non-current assets   4,793,701    4,645,585 
           
Total assets  $8,143,213   $13,061,477 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable and accrued expenses  $454,345   $275,412 
Accrued payroll and other employee costs   41,859    41,073 
Due to related party   423    285 
Insurance premium financing   33,736    13,430 
Operating lease liabilities, current   284,622    16,986 
Income tax payables   20,564    1,038 
Deferred revenue   438,862    676,216 
Derivative liability   62,507    121,719 
Other current liabilities   530,070    521,607 
Current liabilities of discontinued operations   -    1,833,294 
Total current liabilities   1,866,988    3,501,060 
           
Non-current liabilities:          
Operating lease liabilities, non-current   71,912    - 
Deferred tax liabilities   211,795    1,039,181 
Non-current liabilities of discontinued operations   -    448,376 
Total non-current liabilities   283,707    1,487,557 
           
Total liabilities   2,150,695    4,988,617 
           
Shareholders’ equity:          
Preferred shares, $0.0001 par value, 20,000,000 shares authorized; Series A convertible preferred shares, 4,000 shares designated, 517 and 1,017 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively; aggregate liquidation preference of $617,916 and $1,158,362 as of September 30, 2026 and December 31, 2025, respectively   351,712    691,858 
Common shares, $0.0001 par value, 200,000,000 shares authorized, 1,515,328 and 1,270,991 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively*   151    127 
Additional paid-in capital   22,309,504    21,902,169 
Accumulated deficit   (16,640,902)   (12,965,525)
Accumulated other comprehensive loss   (27,947)   (58,497)
Total HeartCore Enterprises, Inc. shareholders’ equity   5,992,518    9,570,132 
Non-controlling interests   -    (1,497,272)
Total shareholders’ equity   5,992,518    8,072,860 
           
Total liabilities and shareholders’ equity  $8,143,213   $13,061,477 

 

 
 

 

 

HEARTCORE ENTERPRISES, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

 

   2026   2025   2026   2025 
   For the Three Months   For the Nine Months 
   Ended September 30,   Ended September 30, 
   2026   2025   2026   2025 
Revenues  $162,409   $1,242,985   $269,852   $1,666,519 
Cost of revenues   146,354    141,460    529,562    331,962 
Gross profit (loss)   16,055    1,101,525    (259,710)   1,334,557 
                     
Operating expenses:                    
Selling expenses   34,818    82,036    104,021    296,632 
General and administrative expenses   1,119,034    817,160    2,986,544    2,488,822 
Total operating expenses   1,153,852    899,196    3,090,565    2,785,454 
                     
Income (loss) from continuing operations   (1,137,797)   202,329    (3,350,275)   (1,450,897)
                     
Other income (expenses):                    
Changes in fair value of investments in marketable securities   442,124    20,539    (375,367)   (908,416)
Changes in fair value of investment in warrants   9,142    (146,769)   (7,493)   (74,109)
Changes in fair value of derivative liability   (47,888)   (9,679)   (630)   (9,679)
Interest income   749    843    1,100    3,966 
Interest expenses   (1,909)   (2,695)   (6,386)   (8,569)
Other income   159,034    39,308    186,056    45,632 
Other expenses   (16,398)   (4)   (361,838)   (193)
Total other income (expenses)   544,854    (98,457)   (564,558)   (951,368)
                     
Income (loss) from continuing operations before income tax expense (benefit)   (592,943)   103,872    (3,914,833)   (2,402,265)
Income tax expense (benefit)   (24,277)   2,039    (766,504)   33,377 
Net income (loss) from continuing operations   (568,666)   101,833    (3,148,329)   (2,435,642)
Income (loss) from discontinued operations, net of income tax   (27,768)   249,342    (644,329)   710,942 
Net income (loss)   (596,434)   351,175    (3,792,658)   (1,724,700)
Less: income (loss) from discontinued operations attributable to non-controlling interests   4,166    (82,897)   (117,281)   (171,682)
Net income (loss) attributable to HeartCore Enterprises, Inc.   (600,600)   434,072    (3,675,377)   (1,553,018)
Dividends accrued on Series A convertible preferred shares   (15,206)   (56,222)   (62,530)   (56,833)
Net income (loss) attributable to HeartCore Enterprises, Inc. common shareholders  $(615,806)  $377,850   $(3,737,907)  $(1,609,851)
                     
Other comprehensive income (loss):                    
Foreign currency translation adjustment   (38,193)   (38,370)   (72,706)   9,668 
Cumulative translation adjustment reclassified into earnings due to disposal of discontinued operations   13,380    -    94,751    - 
Total comprehensive income (loss)   (621,247)   312,805    (3,770,613)   (1,715,032)
Less: comprehensive income (loss) attributable to non-controlling interests   4,598    (85,418)   (125,786)   (175,353)
Comprehensive income (loss) attributable to HeartCore Enterprises, Inc.  $(625,845)  $398,223   $(3,644,827)  $(1,539,679)
                     
Net income (loss) from continuing operations attributable to HeartCore Enterprises, Inc. per common share*                    
Basic*  $(0.39)  $0.04   $(2.30)  $(2.22)
Diluted*  $(0.39)  $0.04   $(2.30)  $(2.22)
                     
Income (loss) from discontinued operations per common share*                    
Basic*  $(0.02)  $0.29   $(0.38)  $0.78 
Diluted*  $(0.02)  $0.29   $(0.38)  $0.78 
                     
Net income (loss) attributable to HeartCore Enterprises, Inc. per common share*                    
Basic*  $(0.41)  $0.32   $(2.68)  $(1.43)
Diluted*  $(0.41)  $0.32   $(2.68)  $(1.43)
                     
Weighted average common shares outstanding*                    
Basic*   1,501,177    1,165,539    1,395,177    1,124,484 
Diluted*   1,501,177    1,165,539    1,395,177    1,124,484 

 

 
 

 

 

HEARTCORE ENTERPRISES, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   2026   2025 
   For the Nine Months 
   Ended September 30, 
   2026   2025 
Cash flows from operating activities of continuing operations:          
Net loss  $(3,792,658)  $(1,724,700)
Income (loss) from discontinued operations, net of income tax   (644,329)   710,942 
Net loss from continuing operations   (3,148,329)   (2,435,642)
Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations:          
Depreciation expense   23,023    36,994 
Loss on disposal of property and equipment   -    116,981 
Non-cash lease expense   195,691    28,167 
Gain on termination of lease   -    (9,059)
Deferred income taxes   (796,046)   29,680 
Stock-based compensation   2,031    69,222 
Warrants received as noncash consideration   -    (837,913)
Changes in fair value of investments in marketable securities   375,367    908,416 
Changes in fair value of investment in warrants   7,493    74,109 
Changes in fair value of derivative liability   630    9,679 
Gain on settlement of asset retirement obligations   -    (45,873)
Changes in assets and liabilities:          
Accounts receivable   (32,826)   - 
Prepaid expenses   152,391    114,556 
Other assets   93,367    137,050 
Accounts payable and accrued expenses   178,373    (98,030)
Accrued payroll and other employee costs   988    (43,430)
Due to related party   138    - 
Operating lease liabilities   (191,710)   (21,135)
Income tax payables   19,382    (97,537)
Deferred revenue   (237,354)   (278,421)
Other liabilities   8,458    (4)
Net cash flows used in operating activities of continuing operations   (3,348,933)   (2,342,190)
           
Cash flows from investing activities of continuing operations:          
Purchases of property and equipment   (4,931)   - 
Proceeds from sale of marketable securities   2,076,782    1,071,732 
Advances on loan receivable   (256,932)   - 
Proceeds from sales of discontinued operations, net of cash divested   825,663    - 
Net cash flows provided by investing activities of continuing operations   2,640,582    1,071,732 
           
Cash flows from financing activities of continuing operations:          
Payments for finance lease   -    (12,692)
Repayment of insurance premium financing   (87,694)   (103,303)
Proceeds from issuance of common shares related to at the market offering agreement   -    30,445 
Proceeds from collection of subscription receivable   -    103,942 
Proceeds from exercise of stock options   -    117,000 
Proceeds from issuance of Series A convertible preferred shares and common shares related to securities purchase agreement, net of share issuance costs   -    1,800,000 
Net cash flows provided by (used in) financing activities of continuing operations   (87,694)   1,935,392 
           
Cash flows from discontinued operations:          
Net cash flows used in operating activities of discontinued operations   (119,498)   (511,096)
Net cash flows provided by (used in) investing activities of discontinued operations   (1,432)   29,222 
Net cash flows used in financing activities of discontinued operations   (22,134)   (305,990)
Net cash flows used in discontinued operations   (143,064)   (787,864)
           
Effect of exchange rate changes   (70,259)   26,577 
           
Net change in cash and cash equivalents   (1,009,368)   (96,353)
Cash and cash equivalents - beginning of the period   1,985,962    2,121,089 
Cash and cash equivalents - end of the period  $976,594   $2,024,736 
           
Supplemental cash flow disclosures:          
Interest paid  $32,583   $88,321 
Income taxes paid  $14,197   $131,118 
           
Non-cash investing and financing transactions:          
Insurance premium financing  $108,000   $139,500 
Warrants converted to marketable securities  $142,515   $388,260 
Operating lease right-of-use assets obtained in exchange for operating lease liabilities  $552,577   $23,495 
Issuance of common shares related to equity purchase agreement  $-   $250,000 
Dividends accrued on Series A convertible preferred shares  $62,530   $56,833 
Issuance of common shares for dividends on Series A convertible preferred shares  $67,870   $- 
Series A convertible preferred shares converted to common shares  $340,146   $- 

 

 

 

Filing Exhibits & Attachments

5 documents

Keep reading